Nikolaos Papadantonakis
Nikolaos Papadantonakis publishes mostly in Hematology, Molecular Biology and Genetics, on topics such as Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.
- World rank
- #1,777,340 of 7,710,434 ranked researchers
- Rank in United States
- #546,954 of 1,627,098
- Works
- 60
- Citations
- 1.2k
- Citations per work
- 20.4
What does Nikolaos Papadantonakis research?
Nikolaos Papadantonakis's work is mostly in Medicine (63%), Biochemistry, Genetics and Molecular Biology (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3862.8%
- Medicine3862.8%
- Everything else1322.4%
- Life Sciences914.8%
- 1Hematology32% of their works
- 2Molecular Biology15% of their works
- 3Genetics12% of their works
- 4Oncology8% of their works
- 5Public Health, Environmental and Occupational Health8% of their works
- 6Pathology and Forensic Medicine3% of their works
Research topics
- Acute Myeloid Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Acute Lymphoblastic Leukemia research
- CAR-T cell therapy research
- Multiple Myeloma Research and Treatments
- Retinoids in leukemia and cellular processes
- Cancer therapeutics and mechanisms
Which keywords describe Nikolaos Papadantonakis's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Minimal Residual Disease, JAK2 Mutation, Myelofibrosis, Acute Lymphoblastic Leukemia and BCR-ABL.
- Topoisomerases
- DNA
- International Myeloma Working Group
- Chimeric Antigen Receptor
- Imatinib
- BCR-ABL
- Myelofibrosis
- Minimal Residual Disease
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- JAK2 Mutation
- Acute Lymphoblastic Leukemia
- Childhood Cancer
- CAR T Cells
- Diagnosis Criteria
- Acute Promyelocytic Leukemia
- Retinoic Acid
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prognostic Factors402 topics
- AML271 topic
- Acute Myeloid Leukemia271 topic
- Minimal Residual Disease182 topics
- JAK2 Mutation161 topic
- Myelofibrosis161 topic
- Acute Lymphoblastic Leukemia131 topic
- BCR-ABL131 topic
- Childhood Cancer131 topic
- Imatinib131 topic
- CAR T Cells71 topic
- Chimeric Antigen Receptor71 topic
- Diagnosis Criteria51 topic
- International Myeloma Working Group51 topic
- Acute Promyelocytic Leukemia41 topic
- DNA41 topic
- Retinoic Acid41 topic
- Topoisomerases41 topic
Where does Nikolaos Papadantonakis work?
Nikolaos Papadantonakis's main affiliation in the publication record is University of Alabama at Birmingham, United States.
How many publications and citations does Nikolaos Papadantonakis have?
OpenAlex counts 60 works and 1,221 citations for Nikolaos Papadantonakis, an h-index of 16, ranking #1,777,340 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nikolaos Papadantonakis. Posts are plain text and can be reported.